3Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B. E.S.T. kidney) investigators. Intensive Care Med, 2007, 33: 1563-1570
4Shimizu T, Endo Y, Tsuchihashi H, et al. Endotoxin apheresis for sepsis. Transfus Apher Sci, 2006, 35: 271- 282.
5Ronco C, Cruz D, Bellomo R. Continuous renal replacement in critical illness. Contrib Nephrol, 2007, 156: 309-319.
6Cole L, Bellomo R, Davenport P, et al. Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Organs, 2004, 27: 388-397.
7Leone M, Boutiere-Albanese B, Valette S, et al. Ceil adhesion molecules as a marker reflecting the reduction of endothelial activation induced by glueocorticoids. Shock, 2004, 21: 311-314.
8Brull DJ, Sanders J, Rumley A, et al. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart, 2002, 87: 252-255.
9Gando S, Kameue T, Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost, 2002, 88: 943-949.
10Yonekawa C continuous Nakae H, Tajimi K endotoxin apheresis et al. Combining and continuous hemodiafihration in the treatment of patients with septic multiple organ dysfunction syndrome. Ther Apher Dial, 2006, 10: 19-24.
